About Us
Industry Experts
Bionoid is a private, hemp-based cannabinoid extraction and processing company with licensed operations in the U.S., Canada and Ecuador. We focus on large-scale, ecologically sustainable hemp cultivation through farming partnerships in Latin America; and on pharmaceutical-grade processing of high-quality, low-cost cannabinoids as the foundation of our global cannabis business.
Our International Reach
Bionoid has developed an expertise in international markets including the EU, Latin America and Canada. The company has future plans to expand operations to include the large, emerging Asian market.
Regulatory Compliance
Bionoid has developed an expertise in proactive regulatory compliance through its team’s 10 years in the cannabis and hemp industries in the U.S., Canada and Latin America. We only work with companies that are compliant in quality and manufacturing procedures, policies and systems, and that can demonstrate Good Manufacturing Practices (GMPs), Good Production Practices (GPPs) and/or ISO (International Organization for Standardization) standards.
News
July 11, 2022 - Bionoid Inc. engages Soft Landing Agency Ecuador to jointly promote cannabis/hemp investment, employment, innovation, and production in Ecuador.
August 4, 2022 - Bionoid Inc. adds management depth through appointment of Jeffrey Meyers to CEO and Mark Goldhar to CFO.
August 13, 2022 - Bionoid Inc. signs $20 million Letter of Intent with Atlantic Biomass LLC on collaboration to produce commercial quantities of Sustainable Aviation Fuels from residual hemp biomass.
August 25, 2022 - Bionoid Inc. announces acquisition of Empress Agri Sales Inc., a private company that holds a Canadian Cannabis Medical Sales License and an Industrial Hemp License.
September 13, 2022 - Bionoid Inc. announces acquisition of IHP LATAM S.A.S., a private company that is at the forefront of the rapidly developing cannabis business in Ecuador.
December 24, 2022 - Bionoid Inc. announced today that it has signed a lease for its new extraction facility in Manta, Ecuador. To view, please visit: https://earth.google.com/web/search/Bionoid,+Inc.,+sin,+0,+Manta,+Ecuador/@-0.9734001,-80.644821,46.70177291a,1056.37158452d,35y,0h,45t,0r/data=Co8BGmUSXwokMHg5MDJiZTVmYjg3NjdkNTlmOjB4YWQwMGU2ZTBhZDUxNTA0GUeKbfcXJu-_IYmxTL9EKVTAKiVCaW9ub2lkLCBJbmMuLCBzaW4sIDAsIE1hbnRhLCBFY3VhZG9yGAIgASImCiQJCRS1vV767r8R_pExopU7778ZoLoJeh4pVMAhFcRPR5opVMAoAg
March 24, 2023 - Bionoid, Inc. announced that it has received signed purchase agreements from 2 European pharma companies totalling $8 million for Bionoid's CBD isolate. First delivery of the isolate is scheduled to begin in late-Q3/2023.
May 19, 2023 - Bionoid, Inc. is pleased to announce that it has just received the Number 1 and 5 Cannabis Licenses from the Government of Ecuador. The Number 1 License allows for the importation and commercialization of hemp seeds and cuttings (including seeds for industrial use) and the Number 5 License is for hemp processing and production of hemp derivatives. Bionoid is now licensed to (I) import and sell hemp seeds and to produce hemp-based cannabinoids in Ecuador and to export its products globally; (ii) import all cannabinoids into Canada and to export globally; and (iii) import hemp-based cannabinoids into the United States.